Figure - PMC

Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2020 May 1.

Published in final edited form as: Hepatology. 2019 Mar 10;69(5):2048–2060. doi: 10.1002/hep.30482

Figure 3: — (A) Significantly increased HLA-DR positive CD8+ T cells at D28 compared with D0 (P=0.0002) as well as D56 compared with D0 (P=0.046). Horizon line represented median. (B) Suppressed 4–1BB–positive CD8 T cell count after the treatment (P=0.012 and P=0.038). Horizon line represented median. (C) Comparison of the change of immune cell profiling between BTC and HCC cohort treated with CTLA-4 blockade and microawave ablation. Bar represented upper and lower limit of cell count of individual subset and dot symbol as mean.

Figure 3: — (A) Significantly increased HLA-DR positive CD8+ T cells at D28 compared with D0 (P=0.0002) as well as D56 compared with D0 (P=0.046). Horizon line represented median. (B) Suppressed 4–1BB–positive CD8 T cell count after the treatment (P=0.012 and P=0.038). Horizon line represented median. (C) Comparison of the change of immune cell profiling between BTC and HCC cohort treated with CTLA-4 blockade and microawave ablation. Bar represented upper and lower limit of cell count of individual subset and dot symbol as mean.